ArticleClinical drug investigation2023

Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study.

Axel De Greef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.